Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) just unveiled an announcement.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced the results of its Extraordinary General Meeting (EGM) and H Shareholders’ Class Meeting, where all proposed resolutions were passed. This development is part of a proposed conditional privatization by Sunshine Lake Pharma Co., Ltd. through a merger by absorption, which includes the withdrawal of the company’s listing and a proposed special dividend. The approval of these resolutions marks a significant step in the company’s strategic reorganization, potentially impacting its market presence and shareholder value.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company based in the People’s Republic of China, focusing on the development and production of various pharmaceutical products. The company operates within the healthcare and pharmaceutical industry, with a market focus on providing medical solutions and products.
Average Trading Volume: 9,350,180
Technical Sentiment Signal: Buy
Current Market Cap: HK$15.31B
See more data about 1558 stock on TipRanks’ Stock Analysis page.